Round 1 Winners!
Proof of Usefulness Report

Cofactor Genomics

Analysis completed on 3/23/2026

+431.2
Proof of Usefulness Score
Certified Problem Solver

Cofactor Genomics demonstrates strong technical innovation and real-world utility in the field of immunotherapy diagnostics using RNA and machine learning. However, the evaluation is heavily penalized due to low-quality, exaggerated responses in the submission, such as claiming the audience is 'everyone' and that 'most people have used my product'. While a team size of 125 suggests legitimate operational scale, the vague financial metrics and poor response quality limit the final score.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+212.5
Audience Reach Impact+30.0
Technical Innovation+120.0
Evidence Of Traction+37.5
Market Timing Relevance+85.0
Functional Completeness+5.0
Subtotal+490
Usefulness Multiplierx0.88
Final Score+431

Project Details

Description
Cofactor Genomics’s mission is to create diagnostics that have the ability to predict the patients that can benefit from immunotherapies. Using more insightful multidimensional biomarkers created with RNA and machine learning, Cofactor’s diagnostics offer greater predictive power than any current test. Instead of searching for isolated, single-analyte biomarkers or DNA mutations, Cofactor’s products create multidimensional biomarkers that better capture the complex immune response at the site of a tumor. Cofactor Genomics empowers clinicians to be better informed while making treatment decisions to improve patient outcomes.

Algorithm Insights

Market Position
Strong market validation with clear user adoption patterns
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline